Analyst Ratings for Arcus Biosciences (RCUS) [Buys]
RCUS Rating Summary
RCUS Price Target Summary
- Highest: $70.00 (BTIG)
- Lowest: $23.00 (BofA Securities)
- Average: $41.57
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$41.57 (+184.9%)
* Over Last 12-Mos
Rating Score: 8.5 / 10
Percentile Rank: 86%
Avg. $ Target:
$41.57 (+184.9%)
* Over Last 12-Mos
Rating Score: 8.5 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/16/2024 | Truist Securities | Asthika Goonewardene | New Coverage | Buy (N/A) |
50.00 (N/A) |
16.58 (14.59) |
-12% | Details |
| 10/11/2022 | Morgan Stanley » Updated 11/13/2023 |
Terence Flynn | New Coverage | Overweight (N/A) |
35.00 (38.00) |
26.15 (14.59) |
-44.21% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
